OBIO Opens Canadian Health Investment Showcase in New York City, Connecting Canada’s High Potential Health Science Companies with Premier US Investors

The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce the opening of the Canadian Health Investment Showcase in New York, NY, on November 5 and 6, 2018.

The Canadian Health Investment Showcase will feature 18 of Canada’s highest potential companies meeting with more than 35 US investors and VCs in New York City to drive investment in Canada’s health science industry.

OBIO is excited by the opportunities for investments and partnerships that the Canadian Health Investment Showcase will create. The overwhelming desire from both US investors and Canadian companies to be part of the Showcase ensures that this event will create unparalleled prospects for both North America’s premier private equity investors and Canada’s most promising health science companies.
— Gail Garland, OBIO President and CEO

Over two days at the Consulate General of Canada in New York, the Canadian Health Investment Showcase features hundreds of one-on-one meetings between companies and US investors, as well as panel discussions on cross-border investing in the health science industry and a keynote on trends in health investing this year.

Creating a dynamic environment for health science companies to meet with targeted US health investors is an opportunity not just for individual companies but the entire Canadian health science industry. I am not only pleased to join the delegation of companies at the Canadian Health Investment Showcase but also to congratulate OBIO on delivering an unprecedented event focused on the needs of Canadian companies.
— Dr. Jeremy Bridge-Cook, CEO of Rna Diagnostic

To find out more, click here to read the full press release.

Previous
Previous

Focal Healthcare Announces FDA and Health Canada Clearance

Next
Next

Winterlight Technology Shows Positive Results In Study of Alzheimer’s Disease